Healthcare Business Management Association - HBMA
Leading the Business of Healthcare Login
Coronavirus Disease (COVID-19) Coronavirus Disease (COVID-19) - HBMA Healthcare Business Management Association

Coronavirus Disease (COVID-19) Update



  • The Senate Banking Committee held a hearing on protecting consumers from financial fraud during the COVID-19 economic recovery.

White House and Federal Agencies

  • The CDC issued a new eviction ban through October 3rd. The ban applies to areas with high levels of COVID-19 transmission. The original ban expired on August 1st. The White House initially refused to extend the moratorium citing a Supreme Court decision in a case challenging the CDC’s authority to issue the moratorium. The House of Representatives tried to pass legislation that would give the CDC the authority but was not able to do so. It is not yet clear if a legal challenge will block this moratorium.
  • The White House is planning a global summit for world leaders to discuss ending the pandemic.
  • The White House held private meetings with major news networks to discuss how they cover new information about COVID-19.
  • The United States has distributed 110 million doses of COVID-19 vaccines to other countries. 

Economy, Vaccine, Testing and Treatment

  • Vaccination rates have significantly increased in the last few days.
  • The delta variant accounts for 93 percent of cases in the U.S.
    • Some experts think we could reach a peak in delta cases as early as this month.
    • NIAID Director Dr. Anthony Fauci warned about the possible emergence of new variants.
  • The FDA could give full approval to Pfizer’s COVID-19 vaccine by early November. All COVID-19 vaccines are currently approved under an Emergency Use Authorization (EUA). Some public health experts believe full approval will lead to increase vaccination rates.
  • Moderna says its vaccine is 93 percent effective six months after the second dose was administered.
  • Moderna also believes regular booster shots will be necessary to maintain protection against COVID-19 and its variants.
  • The FDA approved Regeneron’s COVID-19 antibody therapy as a preventative treatment for people with immunocompromising health conditions such as HIV.
  • A new survey from the Kaiser Family Foundation shows consistent levels of vaccine hesitancy. It also shows divergent views on the danger of the delta variant held by vaccinated and unvaccinated respondents.
  • Novavax agreed to provide 200 million doses of its COVID-19 vaccine to the European Union.
  • The World Health Organization (WHO) is asking countries to avoid booster doses so that vaccine supply can be used by other countries to first increase their vaccination rates.
  • San Francisco is considering allowing recipients of the Johnson & Johnson vaccine to receive a dose of the Pfizer or Moderna vaccine as a booster.
  • New research shows that the number of women in the healthcare workforce declined by 27,000 during the first five months of 2021.
  • Preliminary results shows that a new inhalable nanobody treatment based on the immune systems of llamas was an effective treatment against the delta variant.
  • The American Medical Association (AMA) announced a new CPT code for a third dose of the Pfizer COVID-19 vaccine. 
  • The number of new unemployment applications fell by 14,000 to 385,000.

Center for Disease Control and Prevention (CDC) Updates